维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="Shaughnessy JD"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 显示文摘	Shaughnessy JD Jr Zhan F Burington BE	2007	Blood2007，109，6：	1
2	Proteasome inhibitors and bone disease显示文摘	Qiang YW Heuck CJ Shaughnessy JD Jr		0，，03：	1
3	International staging system and metaphase cytogenetic abnormalities in the era of gene expression profiling data in multiple myeloma treated with total therapy 2 and 3 protocols 显示文摘	Waheed S Shaughnessy JD van Rhee F	2011	Cancer2011，117，5：	1
4	Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer显示文摘	Lewis JD Chagpar AB Shaughnessy EA	2010	Cancer2010，116，10：	1
5	Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer显示文摘	Lewis JD Chagpar AB Shaughnessy EA	2010	Canc- er2010，116，10：	1
6	lnternational staging system and metaphase eytogenetie abnormalities in the era of gene expression profiling dala in multiple myeloma treated with total !htrapy 2 and 3 protocols显示文摘	Waheed S Shaughnessy JD van Rhee F	2011	Cancer2011，117，5：	1
7	Seven-year median time to progression with thalidomide for smoldering myeloma:Partial response identifies subset requiring earlier salvage therapy for symptomatic disease显示文摘	Barlogie B Van Rhee F Shaughnessy JD Jr	2008	Blood2008，112，：	1
8	Multiple myeloma 显示文摘	Anderson KC Shaughnessy JD Jr Barlogie B	2002	Hematology Am Soc Hematol Educ Program2002，，：	1
9	Steps after stroke:capturing ambulatory recovery显示文摘	Shaughnessy M Michael KM Sorkin JD	2005	Stroke2005，36，6：	1
10	Overview of bio-logical database mapping services for interoperation between dif-ferent 'omics' datasets显示文摘	Chavan SS Shaughnessy JD Jr Edmondson RD		0，，06：	1
11	Wnt3a signaling within bone inhibits multiple myeloma bone disease and tu- mor growth显示文摘	Qiang YW Shaughnessy Jr JD Yaccoby S	2008	Blood2008，112，2：	1
12	A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1显示文摘	Shaughnessy JD Jr Zhan F Burington BE	2007	Blood2007，109，6：	1
13	Superior re- sults of Total Therapy 3 (2003-33) in gene expression profi- ling-defined low-risk multiple myeloma confirmed in subse- quent trial 2006-66 with VRD maintenance显示文摘	Nair B van Rhee F Shaughnessy JD Jr	2010	Blood2010，115，21：	1
14	A validated gene expression model of high-risk multiple myeloma is defined by disregulated expression of genes mapping chromosome 显示文摘	Shaughnessy JD Zhan F Burington B> et at	2014	Blood2014，109，6：	1
15	A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 显示文摘	Shaughnessy JD Jr Zhan F Burington BE	2007	Blood2007，109，6：	1
16	Multiple myeloma显示文摘	Anderson KC Shaughnessy JD Jr Barlogie B	2002	Hematology2002，1，：	1
17	Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer 显示文摘	Lewis JD Chagpar AB Shaughnessy EA	2010	Cancer2010，116，10：	1
18	Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols显示文摘	Hoering A Crowley J Shaughnessy JD Jr	2009	Blood2009，114，：	1
19	Pharmacogenomics of hortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMIM, as novel high-risk feature in myeloma treated with Total Therapy 3 显示文摘	Shaughnessy JD Jr Qu P Usmani S	2011	Blood2011，118，13：	1
20	A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1 显示文摘	Shaughnessy JD Zhan F Burington BE		Blood0，109，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示